What do systematic reviews say?

Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel

• Interventions for rosacea 2015 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Low

Minocycline 45 mg vs minocycline 45 mg + azelaic acid gel

The review found no eligible studies for this question.

• Interventions for rosacea 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sildenafil plus iNO vs placebo plus iNO

Sildenafil plus iNO showed no clear difference in all‐cause mortality compared with placebo plus iNO (low certainty).

• Sildenafil for pulmonary hypertension in neonates 2017 · Cochrane Headline outcomes only
  RR 1.27 [0.26, 6.28]
  1 study · 24 participants
  Low

Sildenafil plus iNO vs placebo plus iNO

• Sildenafil for pulmonary hypertension in neonates 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  Low

NB‐UVB plus retinoid vs PUVA plus retinoid

• Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

NB‐UVB plus retinoid vs PUVA plus retinoid

NB‐UVB plus retinoid showed no clear difference in percentage of participants reaching PASI 75 compared with PUVA plus retinoid (low certainty).

• Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes only
  RR 0.89 [0.59, 1.35]
  1 study · 60 participants
  Low

NB‐UVB plus retinoid vs PUVA plus retinoid

• Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

NB‐UVB plus retinoid vs PUVA plus retinoid

NB‐UVB plus retinoid showed no clear difference in clearance rate compared with PUVA plus retinoid (low certainty).

• Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for… 2013 · Cochrane Headline outcomes only
  RR 0.93 [0.79, 1.1]
  2 studies · 90 participants
  Low

Allopurinol vs placebo

Allopurinol showed no clear difference in acute gout attacks compared with placebo (moderate certainty).

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  RR 0.64 [0.12, 3.52]
  1 study · 51 participants
  Moderate

Allopurinol vs benzbromarone

Allopurinol showed no clear difference in acute gout attacks compared with benzbromarone (low certainty).

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  RR 0.28 [0.01, 6.58]
  1 study · 55 participants
  Low

Allopurinol vs benzbromarone

Allopurinol showed no clear difference in proportion achieving target serum urate compared with benzbromarone (moderate certainty).

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  RR 0.79 [0.56, 1.11]
  2 studies · 101 participants
  Moderate

Allopurinol vs benzbromarone

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Allopurinol vs benzbromarone

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Allopurinol vs benzbromarone

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Allopurinol vs placebo

Allopurinol probably leads to higher proportion achieving target serum urate compared with placebo (moderate certainty).

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  RR 49.11 [3.15, 765.58]
  1 study · 51 participants
  Moderate

Allopurinol vs benzbromarone

Allopurinol showed no clear difference in withdrawal due to adverse events compared with benzbromarone (low certainty).

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  RR 0.8 [0.18, 3.58]
  2 studies · 91 participants
  Low

Allopurinol vs benzbromarone

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Allopurinol vs placebo

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 51 participants
  GRADE not reported

Allopurinol vs placebo

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Allopurinol vs placebo

The review found no eligible studies for this question.

• Allopurinol for chronic gout 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found